6 results for author:"Maguire-Zeiss K." in Literature citations
Results Customize
| Misfolded alpha-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease. Beraud D., Maguire-Zeiss K.A. Parkinsonism Relat. Disord. 18 Suppl 1:S17-20(2012) · Mapped (7) |
| Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model. Khandelwal P.J., Dumanis S.B., Feng L.R., Maguire-Zeiss K., Rebeck G., Lashuel H.A., Moussa C.E. Mol Neurodegener 5:47-47(2010) |
| Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Lee B.D., Shin J.H., VanKampen J., Petrucelli L., West A.B., Ko H.S., Lee Y.I., Maguire-Zeiss K.A., Bowers W.J., Federoff H.J. et al. Nat. Med. 16:998-1000(2010) · Mapped (8) |
| Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. Feng L.R., Federoff H.J., Vicini S., Maguire-Zeiss K.A. Eur. J. Neurosci. 32:10-17(2010) · Mapped (8) |
| Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Su X., Federoff H.J., Maguire-Zeiss K.A. Neurotox Res 16:238-254(2009) · Mapped (7) |
| Synuclein activates microglia in a model of Parkinson's disease. Su X., Maguire-Zeiss K.A., Giuliano R., Prifti L., Venkatesh K., Federoff H.J. Neurobiol. Aging 29:1690-1701(2008) · Mapped (10) |